This inventor holds 18 USPTO granted patents and 2 EPO patents, primarily in Particle Therapy Technology. Top assignees: Mevion Medical Systems, Inc., Varian Associates, Inc., K.o. Devices, Inc.. Active years: 1976-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Pepperell, MA (US) (1976 - 1978)
- Littleton, MA (US) (2016)
- Bolton, MA (US) (1980 - 2023)
Company Filing History:
12 out of 51 
3 out of 777 
1 out of 1 
Years Active: 1976-2023
Areas of Expertise:
Title: Innovations by Charles D O'Neal, III in Particle Therapy Systems
Introduction
Charles D O'Neal, III is a notable inventor based in Bolton, MA, USA. With a remarkable portfolio comprising 18 patents, O'Neal has made significant contributions to the field of particle therapy systems. His work focuses on enhancing the precision and effectiveness of cancer treatment technologies.
Latest Patents
O'Neal's latest patent involves an innovative scanning system for particle therapy. This system includes a particle accelerator that outputs a beam of charged particles and a scanning system designed to direct this beam across an irradiation target. The scanning system consists of a scanning magnet that facilitates the movement of the beam during scanning, and a control system that ensures uninterrupted movement while delivering precise doses of charged particles. It also synchronously determines the dose delivered at various positions within a depth-wise layer of the target.
Career Highlights
Throughout his career, O'Neal has worked with esteemed companies in the medical technology sector. Notably, he has been associated with Mevion Medical Systems, Inc. and Varian Associates, Inc., where he applied his expertise to advance particle therapy systems. His technical acumen and innovative mindset have contributed to the development of more effective cancer treatments.
Collaborations
O'Neal has collaborated with several talented professionals in the field, including Kenneth P Gall and Adam C Molzahn. These collaborations have fostered a rich exchange of ideas and technology, propelling advancements in particle therapy.
Conclusion
In conclusion, Charles D O'Neal, III stands out as a significant figure in the sphere of medical innovations, particularly in the realm of particle therapy systems. With his impressive array of patents and the collaborative efforts he engages in, O'Neal continues to impact the future of cancer treatment technologies positively. His dedication to enhancing healthcare through innovation remains an inspiration to many in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile